196 related articles for article (PubMed ID: 31062456)
1. Improvement of reproducibility in quantitative susceptibility mapping (QSM) and transverse relaxation rates (
Choi JY; Lee J; Nam Y; Lee J; Oh SH
J Magn Reson Imaging; 2019 Jun; 49(6):1769-1776. PubMed ID: 31062456
[TBL] [Abstract][Full Text] [Related]
2. Multisite reproducibility of quantitative susceptibility mapping and effective transverse relaxation rate in deep gray matter at 3 T using locally optimized sequences in 24 traveling heads.
Naji N; Lauzon ML; Seres P; Stolz E; Frayne R; Lebel C; Beaulieu C; Wilman AH
NMR Biomed; 2022 Nov; 35(11):e4788. PubMed ID: 35704837
[TBL] [Abstract][Full Text] [Related]
3. Quantitative susceptibility mapping across two clinical field strengths: Contrast-to-noise ratio enhancement at 1.5T.
Ippoliti M; Adams LC; Winfried B; Hamm B; Spincemaille P; Wang Y; Makowski MR
J Magn Reson Imaging; 2018 Nov; 48(5):1410-1420. PubMed ID: 29659131
[TBL] [Abstract][Full Text] [Related]
4. STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping.
Chen Y; Liu S; Wang Y; Kang Y; Haacke EM
Magn Reson Imaging; 2018 Feb; 46():130-139. PubMed ID: 29056394
[TBL] [Abstract][Full Text] [Related]
5. Subcortical gray matter segmentation and voxel-based analysis using transverse relaxation and quantitative susceptibility mapping with application to multiple sclerosis.
Cobzas D; Sun H; Walsh AJ; Lebel RM; Blevins G; Wilman AH
J Magn Reson Imaging; 2015 Dec; 42(6):1601-10. PubMed ID: 25980643
[TBL] [Abstract][Full Text] [Related]
6. Deep gray matter iron measurement in patients with liver cirrhosis using quantitative susceptibility mapping: Relationship with pallidal T
Lee S; Nam Y; Jang J; Na GH; Kim DG; Shin NY; Choi HS; Jung SL; Ahn KJ; Kim BS
J Magn Reson Imaging; 2018 May; 47(5):1342-1349. PubMed ID: 28815906
[TBL] [Abstract][Full Text] [Related]
7. Cerebral OEF quantification: A comparison study between quantitative susceptibility mapping and dual-gas calibrated BOLD imaging.
Ma Y; Sun H; Cho J; Mazerolle EL; Wang Y; Pike GB
Magn Reson Med; 2020 Jan; 83(1):68-82. PubMed ID: 31373088
[TBL] [Abstract][Full Text] [Related]
8. Spatiotemporal variations of magnetic susceptibility in the deep gray matter nuclei from 1 month to 6 years: A quantitative susceptibility mapping study.
Ning N; Liu C; Wu P; Hu Y; Zhang W; Zhang L; Li M; Gho SM; Kim DH; Guo H; Yang J; Jin C
J Magn Reson Imaging; 2019 Jun; 49(6):1600-1609. PubMed ID: 30569483
[TBL] [Abstract][Full Text] [Related]
9. Quantitative susceptibility mapping using single-shot echo-planar imaging.
Sun H; Wilman AH
Magn Reson Med; 2015 May; 73(5):1932-8. PubMed ID: 24938830
[TBL] [Abstract][Full Text] [Related]
10. Cerebral metabolic rate of oxygen (CMRO
Cho J; Kee Y; Spincemaille P; Nguyen TD; Zhang J; Gupta A; Zhang S; Wang Y
Magn Reson Med; 2018 Oct; 80(4):1595-1604. PubMed ID: 29516537
[TBL] [Abstract][Full Text] [Related]
11. Robust spinal cord resting-state fMRI using independent component analysis-based nuisance regression noise reduction.
Hu Y; Jin R; Li G; Luk KD; Wu EX
J Magn Reson Imaging; 2018 Nov; 48(5):1421-1431. PubMed ID: 29659087
[TBL] [Abstract][Full Text] [Related]
12. Multi-centre, multi-vendor reproducibility of 7T QSM and R
Rua C; Clarke WT; Driver ID; Mougin O; Morgan AT; Clare S; Francis S; Muir KW; Wise RG; Carpenter TA; Williams GB; Rowe JB; Bowtell R; Rodgers CT
Neuroimage; 2020 Dec; 223():117358. PubMed ID: 32916289
[TBL] [Abstract][Full Text] [Related]
13. Cerebral metabolic rate of oxygen (CMRO
Zhang J; Zhou D; Nguyen TD; Spincemaille P; Gupta A; Wang Y
Magn Reson Med; 2017 May; 77(5):1762-1773. PubMed ID: 27120518
[TBL] [Abstract][Full Text] [Related]
14. Quantitative susceptibility mapping (QSM) and R
Feng X; Deistung A; Reichenbach JR
Z Med Phys; 2018 Feb; 28(1):36-48. PubMed ID: 28601374
[TBL] [Abstract][Full Text] [Related]
15. Scan-Rescan Repeatability and Impact of B
Yarnykh VL; Kisel AA; Khodanovich MY
J Magn Reson Imaging; 2020 Jun; 51(6):1789-1798. PubMed ID: 31737961
[TBL] [Abstract][Full Text] [Related]
16. Quantitative susceptibility mapping (QSM) as a means to monitor cerebral hematoma treatment.
Zhang Y; Wei H; Sun Y; Cronin MJ; He N; Xu J; Zhou Y; Liu C
J Magn Reson Imaging; 2018 Oct; 48(4):907-915. PubMed ID: 29380461
[TBL] [Abstract][Full Text] [Related]
17. Rapid automated liver quantitative susceptibility mapping.
Jafari R; Sheth S; Spincemaille P; Nguyen TD; Prince MR; Wen Y; Guo Y; Deh K; Liu Z; Margolis D; Brittenham GM; Kierans AS; Wang Y
J Magn Reson Imaging; 2019 Sep; 50(3):725-732. PubMed ID: 30637892
[TBL] [Abstract][Full Text] [Related]
18. Quantitative susceptibility mapping for susceptibility source separation with adaptive relaxometric constant estimation (QSM-ARCS) from solely gradient-echo data.
Kan H; Uchida Y; Kawaguchi S; Kasai H; Hiwatashi A; Ueki Y
Neuroimage; 2024 Aug; 296():120676. PubMed ID: 38852804
[TBL] [Abstract][Full Text] [Related]
19. Joint 2D and 3D phase processing for quantitative susceptibility mapping: application to 2D echo-planar imaging.
Wei H; Zhang Y; Gibbs E; Chen NK; Wang N; Liu C
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26887812
[TBL] [Abstract][Full Text] [Related]
20. Quantitative susceptibility mapping-based cerebral metabolic rate of oxygen mapping with minimum local variance.
Zhang J; Cho J; Zhou D; Nguyen TD; Spincemaille P; Gupta A; Wang Y
Magn Reson Med; 2018 Jan; 79(1):172-179. PubMed ID: 28295523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
